Treatment Innovations
Innovations in cancer treatment are transforming patient care by introducing more precise, effective, and less invasive therapies. Immunotherapy, including checkpoint inhibitors and CAR-T cell therapy, has revolutionized cancer care by harnessing the immune system to target and destroy cancer cells.
Clean energy is key to reducing lung cancer deaths • Wisconsin Examiner
We must come together to combat air pollution and move to clean energy to prevent more needless deaths from lung cancer.
Clinical Studies Conducted at Florida Cancer Specialists & Research Institute Expanding Treatment Options and Improving Outcomes for Patients with Gastrointestinal and Genitourinary Cancers
/PRNewswire/ — Clinical research conducted at Florida Cancer Specialists & Research Institute, LLC (FCS) is expanding treatment options and contributing to…
Woman with cancer reveals the diet she says saved her life
A woman diagnosed with cancer shares her personal story and the dietary changes she believes were crucial in her recovery.
GLP-1 RAs Tied to Higher Thyroid Cancer Risk in First Year of Treatment
THURSDAY, Jan. 30, 2025 (HealthDay News) — The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1
Viral protein Nef enables a step toward off-the-shelf CAR T cell therapy for cancer
CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a patient’s own immune T cells and engineering them to recognize specific targets on the surface of the cancer cell.
New research shines light on position-specific hallmarks of cancer
A team led by the Cancer Immunogenomics group at the Josep Carreras Leukaemia Research Institute, the Computational Biology group at the Barcelona Supercomputing Center and the Germans Trias i Pujol Research Institute shows, for the first time, that within a tumor, the expression of the different hallmarks of cancer is not cell-specific, but rather position-specific.
MPS2 test validated for detection of high-grade prostate cancer in non-DRE urine
“MPS2 could potentially improve the health of our patients by avoiding overdiagnosis and overtreatment and allowing us to focus on those who are most likely to have aggressive cancers," says Ganesh S. Palapattu, MD, FACS.
Dewpoint Therapeutics Announces DPTX3496 as a Development Candidate for the Treatment of Colorectal, Breast, and Lung Cancers
Dewpoint Therapeutics has announced the selection of DPTX3496 as a
Researchers use “hallmarks of cancer” to understand tumour growth
A team led by the Cancer Immunogenomics group at the Josep Carreras Leukaemia Research Institute, the Computational Biology group at the Barcelona Supercomputing Center and the Germans Trias i Pujol Research Institute shows, for the first time, that within a tumour, the expression of the different hallmarks of cancer is not cell-specific, but rather position-specific.
World Cancer Day 2025: Progress in Awareness and Treatment – The Open News
World Cancer Day, an annual global event aimed at increasing awareness of cancer, advancing education, and spurring action to eradicate the illness, is celebrated on February 4th. As World Cancer Day 2025 approaches, it’s a chance to acknowledge the enormous progress that has been made in cancer awareness, early detection, and treatment while also acknowledging […]
Research Spotlight: Advances in Pancreatic Cancer Research and Key Insights from ASCO GI 2025
PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit outlines the latest advances in pancreatic cancer and offers key insights from ASCO GI 2025.
AI-powered breast screening helps women detect breast cancer early
A casual stroll down San Francisco’s Union Street in early January led 38-year-old Jenna Williams to a life-saving discovery.
Can robots like Roxy revolutionise cancer surgery?
n operating theatre D at Glasgow’s Royal Infirmary, gynaecological oncologist Dr Kevin Burton is directing four arms of a robot, affectionately named Roxy.
A simpler, safer treatment for aggressive breast cancer
A simpler, safer treatment for aggressive breast cancer
Eight ways to reduce your risk of bowel cancer
Around half of all bowel cancers could be prevented by having a healthier lifestyle
FDA Approves Trastuzumab Deruxtecan for Pretreated HER2-Low and -Ultralow Metastatic Breast Cancer
The FDA approved T-DXd for unresectable/metastatic HR+, HER2-low/-ultralow breast cancer that progressed on endocrine therapy in the metastatic setting.
Kazia Therapeutics announces the launch of a groundbreaking trial with paxalisib in combination with immunotherapy in women with advanced breast cancer
/PRNewswire/ — Kazia Therapeutics Limited (NASDAQ: KZIA) an oncology-focused drug development company, is pleased to announce the regulatory approval and…
Navigating nutrition during cancer treatment: A dietitian's advice
During cancer treatment, our bodies require optimal nourishment, so eating well is especially important. Unfortunately, the treatments themselves—including chemotherapy and radiation—can interfere with appetite and digestion, making it harder to consistently eat healthy foods or even eat much at all. Filling your fridge and pantry with a variety of foods before treatment begins and being […]
Study Expands Knowledge of Prognostic Markers in Extranodal NHL
Extranodal non-Hodgkin lymphoma (NHL) makes up over one-third of NHL cases, yet remains understudied and in need of deeper research considerations.
Bowel Cancer Breakthrough: Bacteria That Causes Grim Infection Could Be Key to New Treatments
Scientists have discovered that a specific bacterium associated with severe infections may hold the key to developing new treatments for bowel cancer.
New Insights into Cancer Treatment Emerge
Recent studies have provided new insights into cancer treatment, potentially paving the way for more effective therapies.
Roche’s Itovebi Rivals Novartis and AZ, Bolsters Its Benefits Profile with Overall Survival Win
Roche’s cancer drug Itovebi has demonstrated improved overall survival rates, positioning it as a strong competitor against treatments from Novartis and AstraZeneca.
In HER2+ colorectal cancer, anti-HER2 therapy may be less toxic alternative
Patients whose metastatic colorectal cancer has progressed following chemotherapy and who lack mutations in the RAS and BRAF genes (RAS/BRAF wild-type) are typically treated with EGFR inhibitors. For those whose tumors also demonstrate HER2 amplification (extra copies of the HER2 gene), this therapy may be less effective.
Navigating nutrition during cancer treatment: A dietitian’s advice
During cancer treatment, our bodies require optimal nourishment, so eating well is especially important.
